GSK PLANS $250 MILLION EQUITY INVESTMENT IN VIR BIOTECHNOLOGY

Highlights

• GSK and Vir Biotechnology will focus on making drugs and vaccines against COVID-19

• Vir Biotechnology will continue it’s partnership with other companies

• Shares of Vir Biotechnology rose by 30 percent on the Nasdaq

Pharm...

PARIS: HYPED MALARIA DRUG INEFFECTIVE?

Highlights

• Hydroxychloroquine was used in treatment of COVID-19

• U.S. President Trump touted the medicine to be promising against coronavirus

Doctors in France’s Pitie Salpetriere hospital have stated that the use of a malaria medicine named Hydrox...